scispace - formally typeset
R

Rachel F. Brem

Researcher at George Washington University

Publications -  93
Citations -  2550

Rachel F. Brem is an academic researcher from George Washington University. The author has contributed to research in topics: Breast cancer & Mammography. The author has an hindex of 25, co-authored 90 publications receiving 2200 citations. Previous affiliations of Rachel F. Brem include Washington University in St. Louis & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy.

TL;DR: Because ADH was underdiagnosed in 25% of the lesions, it is recommended that surgical excision be performed whenever ADH is found in tissue obtained from 11-gauge directional vacuum-assisted breast biopsy.
Journal ArticleDOI

Screening Breast Ultrasound: Past, Present, and Future

TL;DR: Breast ultrasound for the detection of breast cancer in the screening environment, as well as strategies for integrating screening breast ultrasound, including automated breast ultrasound are discussed.
Journal ArticleDOI

Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.

TL;DR: BSIG has high sensitivity and moderate specificity helping detect breast cancers and helped detect occult cancer not visualized at mammography or ultrasonography in six patients.
Journal ArticleDOI

Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision.

TL;DR: All patients with lobular neoplasia at core or vacuum-assisted biopsy should undergo surgical excision until further differentiating criteria can be determined, and significant sampling error occurs regardless of the type of core biopsy device, number of specimens obtained, histologic-radiographic concordance, mammographic appearance, and complete excision of the lesion as determined by imaging.
Journal ArticleDOI

miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.

TL;DR: The findings suggest that miR-638 plays an important role in TNBC progression via BRCA1 deregulation, and might serve as a potential prognostic biomarker and therapeutic target for breast cancer.